Clinical Trial Results:
Psoriasis-topoproteome under ustekinumab treatment (PIROUETTE-Study)
- as an interventional observation study (phase IV) within approved label and indication and with minimal invasive taking of skin biopsies
- as an investigator originated proposal (IOP) / investigator initiated study/trial (IIS/T)
according to AMG and GCP regulations
Summary
|
|
EudraCT number |
2010-023901-36 |
Trial protocol |
DE |
Global completion date |
22 Jan 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
21 Mar 2021
|
First version publication date |
21 Mar 2021
|
Other versions |
|
Summary report(s) |
Study report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.